Transcription Factor-Targeted Therapies in Inflammatory Bowel Disease

Although the causes of inflammatory bowel disease currently are not fully understood, increasing evidence implicates cytokines as key factors in the development of this disorder. The rationale for cytokine-targeted therapy for inflammatory bowel disease has been refined significantly, and clinical s...

Full description

Saved in:
Bibliographic Details
Published inDigestion Vol. 63; no. Suppl 1; pp. 68 - 72
Main Authors Mitsuyama, Keiichi, Suzuki, Asuka, Tomiyasu, Nobuo, Takaki, Kosuke, Toyonaga, Atsushi, Sata, Michio
Format Journal Article Conference Proceeding
LanguageEnglish
Published Basel, Switzerland Karger 01.01.2001
S. Karger AG
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Although the causes of inflammatory bowel disease currently are not fully understood, increasing evidence implicates cytokines as key factors in the development of this disorder. The rationale for cytokine-targeted therapy for inflammatory bowel disease has been refined significantly, and clinical studies have been initiated. Recent investigations have focused on transcription factors that regulate production and activation of cytokines, including the nuclear factor-ĸB, the p38 mitogen-activated protein kinase, the peroxisome proliferator-activated receptor-γ, and the Janus kinases/signal transducers and activator of transcription pathways. Although their exact role in inflammatory bowel disease is still unknown, further studies may lead to identification of additional possible targets for therapeutic intervention that could improve management of the disease.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
ISBN:3805571836
9783805571838
ISSN:0012-2823
1421-9867
DOI:10.1159/000051914